ARS Wins FDA Approval for Neffy Spray for Children in Anaphylaxis

Neffy 1 mg is the “first significant innovation” for epinephrine delivery in small children aged 4 years and up in over 35 years, according to ARS Pharmaceuticals.

Scroll to Top